US health panel urges restarting J&J COVID-19 vaccinations
April 23, 2021
U.S. health advisers on Friday urged resuming COVID-19 vaccinations with Johnson & Johnson's single-dose shot, saying its benefits outweigh a rare risk of blood clots — in line with Europe's rollout.
Federal health officials uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.
Advisers to the Centers for Disease Control and Prevention said while J&J's vaccine is important for fighting the pandemic, it's also critical that younger women b...
For access to this article please
sign in or
subscribe.
Reader Comments(0)